Base Year
Historical Year
Forecast Year
The global saxagliptin market is expected to grow at a CAGR of 4% in the forecast period of 2024-2032.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The market for saxagliptin is being driven by the rising cases of diabetes across the globe. North America and Europe are the significant markets for saxagliptin globally. This is attributed to a large number of ageing population and the rising prevalence of type II diabetes. The Asia Pacific region is expected to witness a robust growth rate in the forecast period. Countries, especially China and India, are predicted to exhibit a high growth rate of the saxagliptin industry in the Asia Pacific region. Factors such as increasing healthcare expenditure, a large pool of patients, and rising government funding are contributing to the market growth of saxagliptin in the Asia Pacific.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Saxagliptin is the medicine used to treat diabetes. It works by boosting the level of insulin in the body produced after the meal. The product is marketed under the brand name called Onglyza. Saxagliptin acts on a natural hormone in the body, which is called incretins. The product has various side effects such as urinary tract infection, headache, upper respiratory tract infection, and nasopharyngitis. Saxagliptin can also cause complications like stroke and heart attack.
On the basis of dosage, the market is divided into:
Based on distribution channel, the industry can be segmented into:
The regional markets for the product include North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The market for saxagliptin is being driven by the rising incidences of type II diabetes across the globe. The market drivers, such as increased sedentary lifestyle, rising prevalence of obesity, increased government funding, and junk food habits, are contributing to the market growth of saxagliptin. Further, the rising healthcare awareness is expected to fuel the market growth over the forecast period. The market is expanding due to further innovations taking place in the saxagliptin industry. This is further expected to aid the market growth over the forecast period. However, the market is expected to witness a setback owing to the factors, such as stringent regulations for the approval of drugs and the availability of substitutes for the treatment of diabetes.
The report gives a detailed analysis of the following key players in the global saxagliptin market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:
The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis.
| REPORT FEATURES | DETAILS |
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Dosage |
|
| Breakup by Distribution Channel |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Competitive Landscape |
|
| Companies Covered |
|
| Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
| Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
The global saxagliptin market is projected to grow at a CAGR of 4% between 2024 and 2032.
The major drivers of the industry, such as rising disposable incomes, increasing population, rising prevalence of diabetes, a growing number of ageing population, rising healthcare expenditure, large pool of patients, increasingly sedentary lifestyle, and growing prevalence of obesity, are expected to aid the market growth.
The key trends guiding the growth of the market include the rising innovations and increasing government funding.
The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.
The leading dosages of saxagliptin in the market are 2.5 mg and 5 mg, among others.
The major distribution channels in the industry are hospital pharmacy and retail pharmacy, among others.
The major players in the industry are AstraZeneca plc. and Wellona Pharma, among others.
Purchase Full Report
Datasheet
Single User License
One User
Five User License
Five Users
Corporate License
Unlimited Users
How To Order
Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City, 1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124
Share